• News

    Nodality presented novel data from its Immuno-Oncology program.

    Learn more

  • Services

    Enabling smarter drug development

    Learn more

  • PathPro™

    Nodality launched our TCR and CLL PathPro™ products in April 2015.

    Learn more

Recent News

Apr 21, 2015 Nodality Publishes Study Results Confirming the Company’s Diagnostic Can Predict Induction Therapy Response in Elderly Patients with AML. Read More

Apr 02, 2015 Nodality Launches PathPro™ CLL Panels to Enhance Pharmaceutical R&D. Read More

Feb 25, 2015 Nodality, Inc. Presents Data from Immuno-Oncology Program Applying Company’s Novel SCNP™ Platform. Read More